LY573636 sodium

Known as: LY-573636.Na, LY573636-Sodium 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2011
01220112011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
INTRODUCTION Tasisulam sodium (hereafter referred to as tasisulam) is a novel anticancer compound that induces apoptosis and… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2012
2012
Background Tasisulam sodium (hereafter tasisulam), a novel anticancer agent, is being studied in a broad range of tumors. The… (More)
  • table 2
  • figure 1
  • table 3
Is this relevant?
2012
2012
To determine the recommended/maximum tolerated dose (MTD), pharmacokinetics (PK), and safety profile of tasisulam sodium… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2011
2011
BACKGROUND Tasisulam sodium (hereafter, tasisulam) is a novel anticancer agent that induces apoptosis through the intrinsic… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2011
2011
This phase I study was carried out to determine the phase II recommended dose of tasisulam sodium (hereafter, tasisulam), a novel… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?